Actavis nears rescue bid for Allergan: Sources By: CNBC.com News November 16, 2014 at 14:52 PM EST Actavis is nearing a deal to acquire Allergan in a cash and stock deal worth more than $210 per Allergan share, sources tell CNBC. Read More >> Related Stocks: Actavis Plc Valeant Pharmaceuticals International, Inc.
